Home

QVT Fund V LP

CIK 1543904 · last filed 2018-04-04

QVT Fund V LP is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2013. The most recent filing shows the insider bought $45.0M of MYOV on Apr 4, 2018. Across all open-market trades the lifetime net is +$63.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.05M

Companies

3

Total Filings

6

Lifetime Open-Market Net

$63.53M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Myovant Sciences Ltd. (MYOV) Delisted Director 38,341,357 $26.98 $1.03B $45.00M 1 2018-04-04
AGEN 10%+ Owner 369,018 $5.54 $2.05M -$24.90M 1 2015-01-13
ACHILLION PHARMACEUTICALS INC (ACHN) Delisted 10%+ Owner 14,365,571 — — $43.44M 4 2013-07-15

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-04-04 Myovant Sciences Ltd. (MYOV) Delisted Buy (P) +2,220,030 $45.00M EDGAR
2015-01-13 AGEN Sell (S) −4,687,260 -$24.90M EDGAR
2013-07-15 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Buy (P) +802,034 $5.18M EDGAR
2013-07-11 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Buy (P) +781,888 $4.95M EDGAR
2013-07-09 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Buy (P) +1,285,018 $8.07M EDGAR
2013-07-05 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Buy (P) +3,926,496 $25.23M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.